Miller S D, Farmer G, Prives C
Department of Biological Sciences, Columbia University, New York, New York 10027, USA.
Mol Cell Biol. 1995 Dec;15(12):6554-60. doi: 10.1128/MCB.15.12.6554.
The p53 tumor suppressor gene product is a sequence-specific DNA-binding protein that is necessary for the G1 arrest of many cell types. Consistent with its role as a cell cycle checkpoint factor, p53 has been shown to be capable of both transcriptional activation and repression. Here we show a new potential role for p53 as a DNA-binding-dependent regulator of DNA replication. Constructs containing multiple copies of the ribosomal gene cluster (RGC) p53 binding site cloned on the late side of the polyomavirus origin were used in in vitro replication assays. In the presence of p53, the replication of these constructs was strongly inhibited, while the replication of constructs containing a mutant version of the RGC site was not affected by p53. Several tumor-derived mutant p53 proteins were unable to inhibit replication of the construct with wild-type RGC sites. Additionally, the transactivator GAL4-VP16 was unable to inhibit replication of a construct containing GAL4 binding sites adjacent to the polyomavirus origin. We also show that the inhibition by p53 can occur from sites cloned as far as 600 bp from the origin. Preincubation experiments suggest that p53 inhibits replication at a step mediated by ATP, possibly by inhibiting the binding of polyomavirus T antigen to the core origin. The presence of an endogenous p53 binding site in the polyomavirus origin suggests potential mechanisms for the observed inhibition.
p53肿瘤抑制基因产物是一种序列特异性DNA结合蛋白,对许多细胞类型的G1期停滞是必需的。与其作为细胞周期检查点因子的作用一致,p53已被证明既具有转录激活作用,也具有转录抑制作用。在此,我们展示了p53作为DNA复制的DNA结合依赖性调节因子的一种新的潜在作用。将含有多个核糖体基因簇(RGC)p53结合位点拷贝且克隆在多瘤病毒起始位点下游的构建体用于体外复制测定。在p53存在的情况下,这些构建体的复制受到强烈抑制,而含有RGC位点突变体版本的构建体的复制不受p53影响。几种肿瘤来源的突变p53蛋白无法抑制具有野生型RGC位点的构建体的复制。此外,反式激活因子GAL4-VP16无法抑制含有与多瘤病毒起始位点相邻的GAL4结合位点的构建体的复制。我们还表明,p53的抑制作用可以从距离起始位点600 bp处克隆的位点发生。预孵育实验表明,p53在由ATP介导的步骤中抑制复制,可能是通过抑制多瘤病毒T抗原与核心起始位点的结合。多瘤病毒起始位点中内源性p53结合位点的存在提示了观察到的抑制作用的潜在机制。